CN108341802B - 一种抗肿瘤药物克唑替尼的合成方法 - Google Patents
一种抗肿瘤药物克唑替尼的合成方法 Download PDFInfo
- Publication number
- CN108341802B CN108341802B CN201810338369.1A CN201810338369A CN108341802B CN 108341802 B CN108341802 B CN 108341802B CN 201810338369 A CN201810338369 A CN 201810338369A CN 108341802 B CN108341802 B CN 108341802B
- Authority
- CN
- China
- Prior art keywords
- compound
- crizotinib
- reaction
- solution
- dichloromethane
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
Claims (9)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810338369.1A CN108341802B (zh) | 2018-04-16 | 2018-04-16 | 一种抗肿瘤药物克唑替尼的合成方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810338369.1A CN108341802B (zh) | 2018-04-16 | 2018-04-16 | 一种抗肿瘤药物克唑替尼的合成方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN108341802A CN108341802A (zh) | 2018-07-31 |
CN108341802B true CN108341802B (zh) | 2020-09-08 |
Family
ID=62955039
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201810338369.1A Active CN108341802B (zh) | 2018-04-16 | 2018-04-16 | 一种抗肿瘤药物克唑替尼的合成方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN108341802B (zh) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111349083A (zh) * | 2018-12-23 | 2020-06-30 | 江苏万邦生化医药集团有限责任公司 | 一种克唑替尼中间体的除钯方法 |
CN112724077B (zh) * | 2020-12-29 | 2023-07-11 | 武汉利昌医药科技有限公司 | 一种劳拉替尼中间体的合成方法 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104693184A (zh) * | 2015-03-17 | 2015-06-10 | 安润医药科技(苏州)有限公司 | 克唑替尼的合成方法 |
WO2015107553A2 (en) * | 2014-01-15 | 2015-07-23 | Laurus Labs Private Limited | A process for the preparation of crizotinib or an acid addition salt thereof |
-
2018
- 2018-04-16 CN CN201810338369.1A patent/CN108341802B/zh active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2015107553A2 (en) * | 2014-01-15 | 2015-07-23 | Laurus Labs Private Limited | A process for the preparation of crizotinib or an acid addition salt thereof |
CN104693184A (zh) * | 2015-03-17 | 2015-06-10 | 安润医药科技(苏州)有限公司 | 克唑替尼的合成方法 |
Also Published As
Publication number | Publication date |
---|---|
CN108341802A (zh) | 2018-07-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN109020881B (zh) | 一种阿帕替尼的制备方法 | |
CN104262232B (zh) | 尼泰达尼的制备方法 | |
EP2763981B1 (en) | Method for preparing 1-(4-(4-(3,4-dichloro-2-fluorophenylamino)-7-methoxyquinazolin-6-yloxy)piperidin-1-yl)-prop-2-en-1-one hydrochloride and intermediates used therein | |
CN108341802B (zh) | 一种抗肿瘤药物克唑替尼的合成方法 | |
CN104945299A (zh) | 一种维格列汀的高效合成方法 | |
US20180230133A1 (en) | Preparation Method of Rociletinib | |
CN109134434B (zh) | 喹啉或喹唑啉类化合物及其制备方法和应用 | |
CN112062767A (zh) | 一种卢美哌隆的制备方法及其中间体 | |
WO2015103927A1 (zh) | 尼洛替尼中间体的制备方法 | |
CN110642834A (zh) | 来那度胺Lenalidomide的合成方法 | |
CN112279838B (zh) | 一种吡咯替尼的制备方法 | |
CN103450201B (zh) | 手性8‑(3‑氨基哌啶‑1‑基)‑黄嘌呤的制备方法 | |
CN106674084A (zh) | 一种2‑异丙基氧基‑5‑甲基‑4‑(哌啶‑4‑基)苯胺二盐酸盐的制备方法 | |
CN105130887A (zh) | 一种瑞戈非尼的制备方法 | |
CN105924431B (zh) | 化合物克唑替尼的合成工艺 | |
CN104974105A (zh) | 一种制备4-(4-氨基苯基)-3-吗啉酮的方法 | |
WO2015123998A1 (zh) | 一种维达列汀的合成方法 | |
US9604966B2 (en) | Crizotinib preparation method | |
CA3011662A1 (en) | An improved process for the preparation of regorafenib | |
ES2375384T3 (es) | Asimadolina para el tratamiento del síndrome de colon irritable (irritable bowel syndroes). | |
CN109020977B (zh) | 一种Acalabrutinib的制备方法 | |
CN106220607B (zh) | 一种s-3-(哌啶-2-基)-氮杂环丁烷-3-醇的合成方法 | |
CN107365301B (zh) | 一种克唑替尼的合成方法及其中间体制备方法 | |
JP2020070296A (ja) | リナグリプチンの製造法 | |
CN104788482B (zh) | 一种制备2-氨基嘧啶-5-硼酸频那醇酯的方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB03 | Change of inventor or designer information |
Inventor after: Yang Ming Inventor after: Wang Jinguo Inventor after: Shen Chao Inventor after: Wang Dong Inventor after: Yang Yong Inventor after: Ren Yongqi Inventor before: Yang Ming Inventor before: Shen Chao Inventor before: Wang Dong Inventor before: Yang Yong Inventor before: Ren Yongqi |
|
CB03 | Change of inventor or designer information | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Synthesis of an antineoplastic drug clotriminib Effective date of registration: 20210604 Granted publication date: 20200908 Pledgee: Hangzhou joint rural commercial bank Limited by Share Ltd. branch of culture and education Pledgor: ZHEJIANG CHEMTRUE BIOMEDICAL Co.,Ltd. Registration number: Y2021980004407 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20221213 Granted publication date: 20200908 Pledgee: Hangzhou joint rural commercial bank Limited by Share Ltd. branch of culture and education Pledgor: ZHEJIANG CHEMTRUE BIOMEDICAL Co.,Ltd. Registration number: Y2021980004407 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right |